Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy
Recruiting
N/A
Interventional Study
Congenital Cataract
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 1 Month – 18
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Sun Yat-sen University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Selecting the appropriate surgical approach for congenital cataracts presents challenging for ophthalmologists. This prospective, randomized controlled study aims to compare the prognosis of posterior continuous curvilinear capsulorhexis (PCCC) with or without anterior vitrectomy (A-Vit) in treating congenital cataracts.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children with bilateral congenital cataracts without other ocular abnormalities
* Gestational age at birth \>37 weeks
* No more than 18 years old
* Pupils could dilate normally pre-operation
* Have signed a consent form
* Can be followed
Exclusion Criteria:
* Intraocular pre…
Contacts